Universal Health Services, Inc. (UHS)
NYSE: UHS · Real-Time Price · USD
189.39
+0.30 (0.16%)
Jun 6, 2025, 4:00 PM - Market closed
Universal Health Services Stock Forecast
Stock Price Forecast
According to 16 professional analysts, the 12-month price target for Universal Health Services stock ranges from a low of $186 to a high of $267. The average analyst price target of $222.31 forecasts a 17.38% increase in the stock price over the next year.
Price Target: $222.31 (+17.38%)
Analyst Consensus: Buy
* Price targets were last updated on Apr 30, 2025.
Analyst Ratings
The average analyst rating for Universal Health Services stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
---|---|---|---|---|---|---|
Strong Buy | 6 | 6 | 6 | 4 | 4 | 4 |
Buy | 3 | 3 | 3 | 3 | 2 | 2 |
Hold | 9 | 9 | 10 | 10 | 11 | 11 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 18 | 18 | 19 | 17 | 17 | 17 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
RBC Capital | RBC Capital | Hold Maintains $211 → $201 | Hold | Maintains | $211 → $201 | +6.13% | Apr 30, 2025 |
Barclays | Barclays | Buy Maintains $249 → $257 | Buy | Maintains | $249 → $257 | +35.70% | Apr 29, 2025 |
Baird | Baird | Buy → Hold Downgrades $274 → $224 | Buy → Hold | Downgrades | $274 → $224 | +18.27% | Apr 15, 2025 |
Guggenheim | Guggenheim | Strong Buy Initiates $208 | Strong Buy | Initiates | $208 | +9.83% | Apr 9, 2025 |
Morgan Stanley | Morgan Stanley | Hold Initiates $200 | Hold | Initiates | $200 | +5.60% | Mar 26, 2025 |
Financial Forecast
Revenue This Year
17.31B
from 15.83B
Increased by 9.34%
Revenue Next Year
18.28B
from 17.31B
Increased by 5.62%
EPS This Year
19.88
from 16.82
Increased by 18.16%
EPS Next Year
21.65
from 19.88
Increased by 8.94%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 18.2B | 19.6B | 20.4B | ||
Avg | 17.3B | 18.3B | 19.2B | ||
Low | 16.6B | 17.3B | 17.9B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 14.8% | 13.2% | 11.6% | ||
Avg | 9.3% | 5.6% | 4.9% | ||
Low | 5.0% | -0.3% | -2.2% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 22.83 | 24.22 | 27.09 | ||
Avg | 19.88 | 21.65 | 24.16 | ||
Low | 18.59 | 19.96 | 22.24 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 35.7% | 21.9% | 25.1% | ||
Avg | 18.2% | 8.9% | 11.6% | ||
Low | 10.5% | 0.4% | 2.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.